ORLANDO, Fla., Sept. 6 /PRNewswire-FirstCall/ -- Vein Associates Of America, Inc. announces the planned acquisition of the Alabama Vascular & Vein Center from John R. Kingsley, MD, FACS, RVT. Dr. Kingsley recently signed the Letter of Intent, which outlines the upcoming transaction allowing his practice to become part of the Vein Associates nationwide network of medical facilities.
“I’m proud to be a part of the Vein Associates family,” says Dr. Kingsley. “With our growing network of medical centers, we can provide an increasing number of patients around the country with the best in vascular treatments.” Dr. Kingsley, recently named Chairman of the Board for Vein Associates Of America, Inc., will be the Physician-in-Charge at the new Alabama Vein Associates center and continue in his role to qualify potential Vein Associates physicians.
“Dr. Kingsley’s nationally recognized expertise in the field of vascular medicine will be utilized by our entire network of facilities,” says Eric Luetkemeyer, Vice President and CFO for the Company. “Our new Birmingham, Alabama medical center will serve as one of our flagship clinics and our state-of-the-art training facility for incoming physicians.”
About Vein Associates Of America, Inc.
Vein Associates Of America, Inc. operates advanced and well-equipped medical facilities devoted exclusively to the treatment of vein disease. The Company has established and is rapidly expanding highly specialized, professional medical treatment centers comprised of new and effective techniques available in vein treatment. For more information, please visit our website: http://www.vrccorp.com / .
Safe Harbor Statement: Forward-looking statements in this release with respect to Cyberquest and Vein Associates Of America Inc. business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond Cyberquest’s or Vascular Relief Centers control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in Cyberquest’s filings with the Securities and Exchange Commission.
Vein Associates Of America, Inc.
CONTACT: Jamison Teske, Public Relations Account Executive, for VeinAssociates Of America, Inc., Office: +1-612-331-3586,jamison@linnihanfoy.com
Web site: http://www.vrccorp.com/